Last week I double-dipped on conferences, going from London Calling to European Society for Human Genetics (ESHG) in Milan. I have a raft of notes and ideas from these, which I'll try to spool out over the next week or two before jumping to a long list of more whimsical ideas I've jotted down. First up are some updates on Roche's SBX sequencing technology, which has now been christened Axelios - which
Nava Whiteford reported in his ASeq newsletter.